English
Français
Deutsch
Italiano
Português
Русский
Español
ไทย
Türkçe
简体中文
日本語
한국어
हिन्दी
Within the last quarter, Coherus BioSciences (NASDAQ:CHRS) has observed the following analyst ratings:
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 9 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 4 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
In the last 3 months, 10 analysts have offered 12-month price targets for Coherus BioSciences. The company has an average price target of $21.6 with a high of $24.00 and a low of $8.00.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
